Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 07, 2020

SELL
$24.87 - $38.56 $833,145 - $1.29 Million
-33,500 Closed
0 $0
Q4 2019

Jan 13, 2020

SELL
$25.43 - $36.67 $386,536 - $557,384
-15,200 Reduced 31.21%
33,500 $1.21 Million
Q3 2019

Oct 09, 2019

BUY
$23.0 - $27.97 $223,100 - $271,309
9,700 Added 24.87%
48,700 $1.33 Million
Q2 2019

Jul 17, 2019

BUY
$22.81 - $28.48 $889,590 - $1.11 Million
39,000 New
39,000 $938,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Polianta LTD Portfolio

Follow Polianta LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polianta LTD, based on Form 13F filings with the SEC.

News

Stay updated on Polianta LTD with notifications on news.